Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ BayWa-Sanierung wird zur Hängepartie (Manager-Magazin) +++ BAYWA VNA Aktie +5,78%

HENRY SCHEIN Aktie

 >HENRY SCHEIN Aktienkurs 
73 EUR    (TradegateBSX)
Ask: 73.5 EUR / 81 Stück
Bid: 72.5 EUR / 83 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
HENRY SCHEIN Aktie über LYNX handeln
>HENRY SCHEIN Performance
1 Woche: +8,5%
1 Monat: +11,4%
3 Monate: +15,6%
6 Monate: +12,8%
1 Jahr: +17,9%
laufendes Jahr: +12,8%
>HENRY SCHEIN Aktie
Name:  HENRY SCHEIN INC. DL-,01
Land:  USA
Sektor:  Handel
ISIN/ Wkn:  US8064071025 / 897961
Symbol/ Ticker:  HS2 (Frankfurt) / HSIC (NASDAQ)
Kürzel:  FRA:HS2, ETR:HS2, HS2:GR, NASDAQ:HSIC
Index:  S&P500
Webseite:  https://www.henryschein.c..
Profil:  Henry Schein, Inc. is a healthcare distribution and technology company that supplies products and services to office-based dental, medical, and veterinary professionals. The company operates through global distribution, specialty products, and techno..
>Volltext..
Marktkapitalisierung:  8412.85 Mio. EUR
Unternehmenswert:  12888.32 Mio. EUR
Umsatz:  11726.41 Mio. EUR
EBITDA:  969.02 Mio. EUR
Nettogewinn:  346.08 Mio. EUR
Gewinn je Aktie:  2.92 EUR
Schulden:  3284.69 Mio. EUR
Liquide Mittel:  120.91 Mio. EUR
Operativer Cashflow:  506.42 Mio. EUR
Bargeldquote:  0.04
Umsatzwachstum:  -1.08%
Gewinnwachstum:  -9.12%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  HENRY SCHEIN
Letzte Datenerhebung:  01.07.26
>HENRY SCHEIN Kennzahlen
Aktien/ Unternehmen:
Aktien: 113.92 Mio. St.
Frei handelbar: 84.78%
Rückkaufquote: 5.85%
Mitarbeiter: 25000
Umsatz/Mitarb.: 0.46 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 5.2%
Bewertung:
KGV: 25.47
KGV lG: 15.59
KUV: 0.71
KBV: 2.95
PEG-Ratio: 8.44
EV/EBITDA: 13.3
Rentabilität:
Bruttomarge: 29.19%
Gewinnmarge: 2.95%
Operative Marge: 5.88%
Managementeffizenz:
Gesamtkaprendite: 3.63%
Eigenkaprendite: 12.01%
>HENRY SCHEIN Peer Group
Handel, Apotheken, Drogerien & Pharmavertrieb
 
26.06.26 - 14:06
Magdent Wins US$150,000 Investment at Dentalcorp′s Demo Day (Business Wire)
 
In the closely contested competition, Oral Genome also won a US$50,000 investment as the runner-up.ORLANDO, Fla.--(BUSINESS WIRE)--Dentalcorp, one of North America's largest dental support organizations, today announced Magdent as the winner of its inaugural Demo Day, with Oral Genome finishing a close second. The live dental technology competition was held on June 24 in Orlando, Florida. Magdent and Oral Genome will receive SAFE investments* of US$150,000 and US$50,000 respectively, with both earning a potential pilot opportunity across Dentalcorp's network of more than 600 practices. A judging panel that included senior leaders from Dentalcorp, Henry Schein One, VideaHealth and Dental Innovation Alliance selected the winners. "The response to Demo Day far surpassed our expectations. The quality and range of the technology was striking, and a reminder that the future of this profession is as bright as the people building it." — Nate Tchaplia, President, Dentalcorp Dentalcorp's Demo Day is ...
23.06.26 - 17:31
Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term (Zacks)
 
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....
11.06.26 - 14:09
This Henry Schein Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday (Benzinga)
 
Wall Street analysts change outlook for top stocks. See upgrades, downgrades, and initiations on analyst ratings page. HSIC stock analysis. Importance Rank:  1 read more...
28.05.26 - 17:30
Here′s Why Henry Schein (HSIC) is a Strong Momentum Stock (Zacks)
 
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....
28.05.26 - 16:45
Is This the Right Time to Keep HSIC Stock in Your Portfolio? (Zacks)
 
Henry Schein is backed by a dental and medical distribution scale, digital dentistry push and acquisitions, but debt and macro headwinds weigh on its outlook....
22.05.26 - 14:03
Henry Schein Announces the Election of William K. “Dan” Daniel as Independent Chairman of the Board (Business Wire)
 
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Board of Directors has elected William K. “Dan” Daniel as Independent Chairman of the Board, effective May 21, 2026. Mr. Daniel succeeds Stanley M. Bergman, who retired from the Board following 44 years as a Director of Henry Schein and was named Chairman Emeritus in recognition of his extraordinary contributions to the Company. Mr. Daniel joined the Henry Schein Board of Directors in May 2025. He possesses decades of board and global executive leadership experience in healthcare and industrial sectors, including serving for 14 years as Executive Vice President at Danaher Corporation (NYSE: DHR), where he oversaw multiple business segments including Danaher's dental portfolio. Mr. Daniel also played a key role in advancing Danaher's business systems and culture, while also serving as a Board Director at E...
21.05.26 - 03:54
Henry Schein Stock: Is Wall Street Bullish or Bearish? (Barchart)
 
Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...
13.05.26 - 02:02
Insiderhandel: Aufsichtsrat kauft Aktien von Henry Schein im Wert von 691900 USD (Insiderkauf)
 
Daniel, William K. - Aufsichtsrat - Tag der Transaktion: 2026-05-11...
05.05.26 - 18:36
Henry Schein (HSIC) Q1 2026 Earnings Transcript (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
05.05.26 - 16:45
Compared to Estimates, Henry Schein (HSIC) Q1 Earnings: A Look at Key Metrics (Zacks)
 
Although the revenue and EPS for Henry Schein (HSIC) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....
05.05.26 - 14:30
Henry Schein (HSIC) Q1 Earnings and Revenues Top Estimates (Zacks)
 
Henry Schein (HSIC) delivered earnings and revenue surprises of +10.30% and +1.15%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?...
05.05.26 - 12:30
Henry Schein Inc. Q1 Sales Increase (AFX)
 
MELVILLE (dpa-AFX) - Henry Schein Inc. (HSIC) reported a profit for first quarter of $107 millionThe company's bottom line came in at $107 million, or $0.92 per share. This compares with $110 mill......
05.05.26 - 12:15
Henry Schein Non-GAAP EPS of $1.32 beats by $0.10, revenue of $3.37B beats by $30M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.05.26 - 12:06
Henry Schein Reports First Quarter 2026 Financial Results (Business Wire)
 
Q1 2026 GAAP diluted EPS of $0.92 compared to $0.88 GAAP diluted EPS in Q1 2025 Q1 2026 non-GAAP diluted EPS of $1.32 compared to $1.15 non-GAAP diluted EPS in Q1 2025 Reaffirming guidance for 2026 sales, non-GAAP diluted EPS, and Adjusted EBITDA Confirming that value creation initiatives are expected to deliver over $200 million of operating income improvement over the next few years, with $125 million run-rate by year-end 2026 MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the first quarter ended March 28, 2026. “I am pleased with our strong first quarter results that reflect continuing momentum from the second half of last year as we grow market share and expand gross margins. Our growth outlook, combined with the progress made on value-creation initiatives and a strong start to the year, reinforces my confidence that we will deliver on our...
04.05.26 - 16:45
Henry Schein Q1 2026 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
30.04.26 - 17:03
Here′s Why Henry Schein (HSIC) is a Strong Growth Stock (Zacks)
 
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....
28.04.26 - 17:31
Henry Schein (HSIC) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
 
Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
28.04.26 - 16:01
Here′s How Henry Schein Is Placed Ahead of Q1 Earnings (Zacks)
 
HSIC heads into Q1 earnings results with steady estimates, a 5.1% revenue growth outlook and strength across distribution, specialty products and tech....
21.04.26 - 12:36
Henry Schein to Webcast First Quarter 2026 Conference Call on Tuesday, May 5, 2026, at 8:00 A.M. ET (Business Wire)
 
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its first quarter 2026 financial results before the stock market opens on Tuesday, May 5, 2026, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Frederick M. Lowery, Chief Executive Officer and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay will be available on the Henry Schein website following the presentation. About Henry Schein, Inc. Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 mil...
17.04.26 - 19:45
Why Henry Schein (HSIC) is Poised to Beat Earnings Estimates Again (Zacks)
 
Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Gott kann nichts logisch Unmögliches tun, doch setzt dies seiner Allmacht keine Grenzen. Er kann nichts Absurdes tun oder erfinden. - Leszek Kolakowski
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!